Zusammenfassungen von Publikationen zum Prader-Willi-Syndrom

Clinical Effects of Treatment for Hypogonadism in Male Adolescents with Prader-Labhart-Willi Syndrome. Hormone Research 2007;68(4):178-184. Eiholzer U, Grieser J, Schlumpf M, l'Allemand D.

Hypothalamic and gonadal components of hypogonadism in boys with Prader-Labhart-Willi syndrome. Journal of Clinical Endocrinology & Metabolism 2006;91:892-898. Eiholzer U, L'Allemand D, Rousson V, Schlumpf M, Gasser T, Girard J, Grüters A, Simoni M.

A daily comprehensive muscle training programme increases lean mass and spontaneos activity in children with Prader-Willi syndrome after 6 months. Journal of Pediatric Endocrinology & Metabolism 2006;19:65-74. Schlumpf M, Eiholzer U, Gygax M, Schmid S, van der Sluis I, l'Allemand D.

Deaths in children with Prader-Willi syndrome. A contribution to the debate about the safety of growth hormone treatment in children with PWS. Hormone Research 2005;63:33-39. Eiholzer U.

Growth hormone and body composition in children younger than 2 years with Prader-Willi syndrome. Journal of Pediatrics 2004;144:753-8. Eiholzer U, L'Allemand D, Schlumpf M, Rousson V, Gasser T, Fusch C.

A comprehensive team approach to the management of patients with Prader-Willi syndrome. Journal of Pediatric Endocrinology & Metabolism 2004;17:1153-1175. Eiholzer U, Whitman BY

Behavioural and emotional disturbances in people with Prader-Willi syndrome. Journal of Intellectual Disability Research 2004;48:47-52. Steinhausen HC, Eiholzer U, Hauffa BP, Malin Z.

Carbohydrate metabolism is not impaired after 3 years of growth hormone therapy in children with Prader-Willi syndrome. Hormone Research 2003;59:239-248. L'Allemand D, Eiholzer U, Schlumpf M, Torresani T, Girard J.

Improving body composition and physical activity in Prader-Willi Syndrome. Journal of Pediatrics 2003; 142: 73-8.Eiholzer U, Nordmann Y, l'Allemand D, Schlumpf M, Schmid S, Kromeyer-Hauschild.

Increased adrenal androgen levels in patients with prader-willi syndrome are associated with insulin, igf-I, and leptin, but not with measures of obesity. Hormone Research 2002; 58: 215-22. L'Allemand D, Eiholzer U, Rousson V, Girard J, Blum W, Torresani T, Gasser T.

Sudden death of an infant with Prader-Willi syndrome - not a unique case? Biology of the Neonate 2002; 82: 139-41. Nordmann Y, Eiholzer U, L'Allemand D, Mirjanic S, Markwalder C.

Fatal Outcome of Sleep Apnoea in PWS during the Initial Phase of Growth Hormone Treatment. A case report. Hormone Research 2002; 58 Suppl 3: 24-6. Eiholzer U, Nordmann Y, l'Allemand D.

Behavioral phenotypes in four mental retardation syndromes: Fetal alcohol syndrome, Prader-Willi syndrome, fragile X syndrome, and tuberosis sclerosis. American Journal of Medical Genetics 2002; 111: 381-7. Steinhausen HC, Von Gontard A, Spohr HL, Hauffa BP, Eiholzer U, Backes M, Willms J, Malin Z.

Growth Hormone Normalises Height, Prediction of Final Height and Hand Length in Children with Prader-Willi Syndrome after 4 Years of Therapy. Hormone Research 2000;53:185-192. Urs Eiholzer, Dagmar l'Allemand.

Cardiovascular risk factors improve during 3 years of growth hormone therapy in Prader-Willi syndrome. European Journal of Pediatrics (2000) 159:835-842. D. l'Allemand, U. Eiholzer, M. Schlumpf, H. Steinert, W. Riesen.

Body Composition Abnormalities in Children with Prader-Willi Syndrome and Long-Term Effects of Growth Hormone Therapy. Hormone Research 2000;53:200-206. U. Eiholzer, D. l'Allemand, I. van der Sluis, H. Steinert, T. Gasser, K. Ellis.

Familial Dysalbuminemic Hyperthyroxinemia in a Swiss Family Caused by a Mutant Albumin (R218P) Shows an Apparent Discrepancy between Serum Concentration and Affinity for Thyroxine. The Journal of Clinical Endocrinology & Metabolism (2000) Vol. 85:2281-2286, No. 8. Silvana Pannain, Michael Feldman, Urs Eiholzer, Roy E. Weiss, Neal H. Scherberg, Samuel Refetoff.

Male Hypogonadism Caused by Homozygous Deletion of Exon 10 of the Luteinizing Hormone (LH) Receptor: Differential Action of Human Chorionic Gonadotropin and LH.The Journal of Clinical Endocrinology & Metabolism (2000) Vol. 85:2281-2286, No. 6. J. Gromoll, U. Eiholzer, E. Nieschlag, M. Simoni.

Does growth hormone therapy improve motor development in infants with Prader-Willi syndrome? European Journal of Pediatrics (2000) 159: 299-301. Urs Eiholzer, Sigrun Malich, Dagmar I'Allemand.

Symptomatic versus substitution growth hormone therapy in short children: from auxology towards a comprehensive multidimensional assessment of short stature and related interventions. Journal of Pediatric Endocrinology & Metabolism 2000; 13: 403-8. Haverkamp F, Eiholzer U, Ranke MB, Noeker M.

Phenotypic heterogeneity of growth and psychometric intelligence in Prader-Willi syndrome: variable expression of a contiguous gene syndrome or parent-child resemblance? American Journal of Medical Genetics 2000; 91: 298-304. Malich S, Largo R, Schinzel A, Molinari L, Eiholzer U.

Body fat determined by skinfold measurements is elevated despite underweight in infants with Prader-Labhart- Willi syndrome. European Journal of Pediatrics 1999;134:222-5. Urs Eiholzer, MD, Werner F. Blum, MD, Luciano Molinari, PhD.

Low insulin, IGF-I and IGFBP-3 levels in children with Prader-Labhart-Willi syndrome. European Journal of Pediatrics (1998) 157: 890-893. U. Eiholzer, K. Stutz, C. Weinmann, T. Torresani, L. Molinari, A. Prader.

Treatment with human growth hormone in patients with Prader-Labhart-Willi syndrome reduces body fat and increases muscle mass and physical performance. European Journal of Pediatrics (1998) 157: 368 - 377. U. Eiholzer, R. Gisin, C. Weinmann, S. Kriemler, H. Steinert T. Torresani, M. Zachmann, A. Prader.

Longitudinal monthly body measurements from 1 to 12 months of age: a study by practitioners for practitioners. European Journal of Pediatrics (1998) 157: 547-552. U. Eiholzer, P. Bodmer, M. Bühler, U. Döhmann, G. Meyer, P. Reinhard, G. Schimert, G. Varga, R. Wälli, R. Largo, L. Molinari.